Characterization of Survival Outcomes and Clinical and Molecular Modulators in Adult Patients with Core-Binding Factor Acute Myeloid Leukemia (CBF-AML): An Alliance Legacy Study
      Google Scholar   
Citation:
Blood vol 140 (suppl 1) 1284–5
Meeting Instance:
ASH 2022
Year:
2022
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171  
Corr. Author:
 
Authors:
                               
Networks:
LAPS-IL057, LAPS-MO011, LAPS-OH007, MD015, NC002, NORTHWELL, OH070   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-20202, CALGB-8461, CALGB-9665
Phases:
N/A
Keywords: